Researcher Lynne Postovit is focused on improving ovarian cancer survival statistics. “Over 50% of the women diagnosed with ovarian cancer will die within 5 years,” Postovit says. “That’s pathetic; we must do a lot better than that.” She and her research team at the University of Alberta are working to detect cancer in its beginning stages with biomarkers. The goal—to develop an ovarian cancer biomarker test in the next 5 years.

свернуть